portfolio overview by geographic region $m 2007-13 78 Table 14: Merck & Co

portfolio overview by geographic region ($m), 2007-13 78 Table 14: Merck & Co. launch portfolio overview ($m), 2007-13 81 Table 15: Merck & Co. core portfolio overview ($m), 2007-13 82 Table 16: Merck & Co. expiry portfolio overview ($m), 2007-13 83 Table 17: Merck & Co. portfolio overview by molecule type ($m), 2001-07 87 Table 18: Merck & Co. product portfolio overview ($m), 2001-07 58 Table 9: Merck & Co.

product portfolio overview ($m), 2007-13 61 Table 10: Merck & Co. product portfolio overview ($m), 2001-07 66 Table 11: Merck & Co. product portfolio overview ($m), 2007-13 69 Table 12: Merck & Co. quarterly global sales update ($m), Q4 2008 31 Table 3: Merck & Co key product developments, 2008 33 Table 4: Merck & Co product deals and alliances, 2008 35 Table 5: Merck & Co technology deals and alliances, 2008 40 Table 6: Merck & Co company announcements, 2008 41 Table 7: Merck & Co future product milestones, 2009-11 45 Table 8: Merck & Co. CHAPTER 1 ABOUT THIS PROFILE 2 Executive summary 2 Quarterly news update 2 Company introduction 2 Company sales 2 Company financials 2 Key products and competitors 3 Data sourcing 3 Sales data 3 Analyst consensus 3 CHAPTER 2 EXECUTIVE SUMMARY 4 Key findings 4 Prescription pharmaceutical sales performance, 2001-13 5 Financial performance, 2001-13 6 Merck & Co.: PharmaVitae forecasts at a glance 7 Strategic insight 8 Introduction 8 Merck & Co an onlooker as M&A redefines Big Pharma 9 Merck & Co.

brands over 07-13and how this threat will mitigate sales growth from new launches *Analyze how Merck & Co will improve its operating performance over 07-13despite a flat sales growth performance, via significant cost restructuring. An interactiveforecasting and analysis tool provides continually updated quantitative andqualitative information. Reasons to Purchase *Benchmark Merck & Co.'s performance against key rivals in the ethicalpharmaceutical sector *Assess the impact of generic erosion across key Merck & Co. NEW YORK--(Business Wire)--Reportlinker announces that a new market research report is available in itscatalogue Merck & Co. Inc: PharmaVitae Profile http:// This analysis examines the historical and forecast performance for Merck & Co.in the Rx pharmaceutical sector.